Hometown:
Roslyn, New York, United States
What is your educational background?
Before coming to Yale, I earned my undergraduate degree in biochemistry and molecular biology from Brown University. I conducted my honors thesis research in a biomedical engineering lab at Brown, which sparked my interest in how engineering principles can be applied to improve medicine. In my sophomore year, I was accepted into the Donald and Vera Blinken FlexMed Early Assurance MD program at the Icahn School of Medicine at Mount Sinai. I could have started medical school right after graduating, but I decided to defer my MD start date to pursue the PMAE master’s at Yale. My goal in this program is to deepen my understanding of personalized medicine and applied engineering before beginning medical school.
Why Yale?
Yale has a distinguished history of medical innovation, being the first institution in the U.S. to treat cancer with chemotherapy and to introduce antibiotics for bacterial infections. The PMAE master’s program at Yale builds on this legacy, equipping students to continue shaping the future of medicine. It offers an unparalleled opportunity to explore applied engineering principles and emerging technologies such as artificial intelligence, 3D printing, augmented/virtual reality, and biotechnologies—all of which are critical to advancing medicine.
What interests you about personalized medicine and applied engineering?
Personalized medicine focuses on tailoring healthcare to the unique needs of each individual, which represents a crucial shift in medical practice. In my future career as a physician-scientist, I'm passionate about advancing the widespread adoption and accessibility of personalized medicine, as I believe it has the potential to vastly improve the health and lives of people everywhere.
What are you most looking forward to about this program?
I’m eager to contribute to the development of personalized treatments that can significantly improve patient outcomes. My master’s thesis, guided by Professors Paul Turner and Jon Koff at YSM, focuses on developing personalized phage therapy to treat drug-resistant Pseudomonas aeruginosa infections in cystic fibrosis patients. I'm excited to be part of this innovative work that could have a profound impact on patients' lives.
What are your hobbies outside of academics?
Outside of class, I enjoy spending time with friends, working out, running, cycling, and exploring nature. I also work for Yale Ventures as an Associate for the Roberts Innovation Fund. In my role, I support Yale engineering faculty and their innovations on the path to commercialization or greatest impact.
What’s next?
I will be attending the Icahn School of Medicine at Mount Sinai following the Yale PMAE program and hope to become a physician-scientist in the future.